Up with The Sun-Star Newsletter

Coronavirus weekly need-to-know: Cruises, travel warnings, declining COVID cases & more

Coronavirus omicron variant and sub-variant make up virus cases. What to know about COVID CDC travel destination alerts, cruises, flatworm named from pandemic.
Coronavirus omicron variant and sub-variant make up virus cases. What to know about COVID CDC travel destination alerts, cruises, flatworm named from pandemic. AP

In the United States, more than 77.6 million people have tested positive for coronavirus as of Saturday, Feb. 12, according to Johns Hopkins University.

About 918,000 Americans have died. Worldwide, there have been more than 409 million confirmed cases of COVID-19.

Additionally, more than 5.8 million across the globe have died from the virus. More than 213 million people in the U.S. are fully vaccinated to date – 64.3% of the population – and 90 million of those people have gotten a booster shot as of Feb. 11, according to Centers for Disease Control and Prevention data.

The agency reports COVID-19 cases and hospitalization rates are dropping nationwide as of Feb. 3. Cases are 53.1% lower as of Feb. 2 compared to when they hit a peak Jan. 15, the CDC says.

The omicron variant made up 96.4% of all sequenced cases the week ending Feb. 5, according to the agency, and the omicron BA.2 sub-variant made up 3.6% of cases.

Here’s what happened between Feb. 6 and Feb. 11:

New monoclonal antibody drug for COVID authorized, FDA says. It works against omicron

A new monoclonal antibody drug has proved to be effective against the coronavirus omicron variant and omicron subvariant, according to the Food and Drug Administration.

The agency has given emergency-use authorization for the drug to be used as a treatment option for those 12 and older and weighing at least 88 pounds with “mild to moderate COVID-19.” It’s “not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19,” the FDA says.

Pharmaceutical company Eli Lilly’s monoclonal antibody — bebtelovimab — received FDA authorization for people who’ve discovered they’re COVID-19 positive and “are at high risk” for being severely affected by the virus, the agency said in a Feb. 11 news release. Additionally, it’s for those “whom alternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.”

For more on the monoclonal antibody, keep reading:

Read Next

Cruises can opt-in to new COVID vaccine guidance, CDC says. What it means for travelers

The Centers for Disease Control and Prevention has unveiled new coronavirus guidelines for the cruise industry, allowing cruise lines to operate under different tiers based on the vaccination status of passengers and crew as part of a new voluntary program.

And those tiers could change how long passengers are recommended to quarantine after exposure to the coronavirus.

In its updated guidelines on Feb. 9, the CDC maintained it’s best to “avoid” cruise travel — and cautioned people should be fully vaccinated against COVID-19 if they can’t resist a vacation on the high seas.

Cruise lines have until Feb. 18 to opt into the COVID-19 Program for Cruise Ships, which separates ships into three tiers.

Keep reading for the vaccination status tiers:

Read Next

9-month old twin dies of COVID, Missouri family says. ‘A piece will always be missing’

Twins Amelia and Claire Peyton won’t have the opportunity to grow up together after one sister died of COVID-19 complications.

Both 9-month-old girls had tested positive for coronavirus, their family said, and only Claire recovered.

Amelia, of Iberia, died Tuesday, Feb. 1, at University Hospital in Columbia, Missouri, KOMU reported.

“She will never be forgotten,” father Brian Petyon shared to Facebook. “She was the best happiest baby she was our world now a piece will always be missing.”

Continuing reading here:

Read Next

7-year-old dies of COVID days after dream of being big sister comes true, TN mom says

A second-grader died this week in Tennessee after COVID-19 triggered an auto-immune response that “shut her little body down,” her family says.

Adalyn Rita Graviss died just a week after her dream of being a big sister became true, according to Knoxville mom Jennifer Kowalski-Graviss, who gave birth to her baby sister Ella on Jan. 28.

“This girl was our whole world,” Kowalski-Graviss wrote Feb. 8 on Facebook.

“She was so brave and so strong. She prayed for so many years to be a big sister and we are so thankful she was able to have all her dreams come true even for a few short days.”

Keep reading below:

Read Next

Which countries have ‘very high’ COVID risk? CDC adds more travel destinations to list

If you’re looking to plan an international trip, it’s important to know that the majority of travel destinations worldwide are considered a “very high” COVID-19 risk compared with others, according to the Centers for Disease Control and Prevention.

Seven countries were added to the CDC’s highest risk category — level four — on Feb. 7, and the agency is urging everyone to “avoid travel to these destinations.”

Now, a total 133 travel spots make up the level four COVID-19 category with the newest additions being Armenia, Cuba, Democratic Republic of Congo, Israel, Japan, Libya and Oman, according to the agency’s COVID-19 Travel Recommendations.

This comes after the CDC upgraded 12 destinations to level four on Jan. 31 including Mexico and South American nations such as Brazil, Chile and Ecuador.

“If you must travel to these destinations, make sure you are fully vaccinated before travel,” the CDC says.

For more on the CDC’s travel alerts, keep reading:

Read Next

Men, women have anxiety over COVID pandemic for different reasons. Study explains why

The COVID-19 pandemic has worsened the anxiety of people all over the world. But a newly published Canadian study found that the risk factors linked to anxiety disorders have differed between men and women.

According to the study, conducted at the University of Toronto and published on Jan. 29, around 1 in 7 Canadians experienced generalized anxiety disorder during the early stages of the pandemic. But anxiety in men was more likely to be driven by exposure to COVID-19 misinformation, whereas anxiety in women was exacerbated by issues like unstable employment.

The study used data from the Canadian Perspective Survey Series and included 1,753 male and 2,016 female participants age 15 and older.

Continue reading about the study’s findings:

Read Next

Woman facing 10 years in prison in COVID fraud joins couple on the run, FBI says

A Southern California woman facing 10 years in prison for her alleged role in a $20 million COVID-19 fraud ring has vanished, joining two others also on the run in the case, FBI officials said.

Tamara Dadyan, 42, of Encino failed to report to begin serving her sentence and cannot be found, the FBI reported Feb. 3 on Twitter.

Her brother-in-law, Richard Ayvazyan, 43, and his wife, Marietta Terabelian, 37, disappeared in August ahead of their own sentencing hearing in the case, McClatchy News reported. They all remain missing as of Feb. 8.

THe FBI is seeking information on Dadyan’s location. Keep reading:

Read Next

Unvaccinated oral surgeon sues after his medical practice shut down in Rhode Island

An unvaccinated oral surgeon has filed a lawsuit in Rhode Island after his medical practice, which saw over 800 patients each month, was shut down over him not getting a COVID-19 vaccine, according to the New Civil Liberties Alliance.

He was banned from work as an oral surgeon, unless he got vaccinated, the same day Rhode Island’s vaccine mandate for healthcare workers went into effect on Oct. 1, according to an order by the state health department.

Now, Dr. Stephen Skoly is suing the state’s Gov. Daniel McKee and the interim director of the state’s health department arguing that “Rhode Island has arbitrarily and unlawfully prevented (him) from practicing medicine.” The lawsuit was filed in the U.S. District Court of Rhode Island by the NCLA on Feb. 4.

The Rhode Island Department of Health declined to comment on the lawsuit. A spokesperson for the governor’s office told McClatchy News that it would not comment on pending litigation.

For more on the case, read on:

Read Next

Meet ‘Humbertium covidum.’ Newly found flatworm takes its name from COVID pandemic

Scientists who discovered two new types of hammerhead flatworms during the COVID-19 pandemic lockdown have dubbed one of the tiny creatures “Humbertium covidum.”

“We decided to name one of the species ‘covidum,’ paying homage to the victims of the pandemic,” Jean-Lou Justine of the Muséum National d’Histoire Naturelle in Paris, said in a news release.

Flatworms are small, alien-looking worms that prey on other worms, snails and slugs in the soil, The Washington Post reported. They are highly invasive.

Some hammerhead flatworms can reach up to 1 meter in size, but Humbertium covidum tops out at about 3 centimeters, a scientific paper by Justine and his team reported.

It has been found in Italy and France, though some records suggest it may also be found in Russia, China and Japan, the paper says. While some flatworms are extremely colorful, Humbertium covidum is metallic black with no stripes.

For more on Humbertium covidum keep reading:

Read Next

Reporters Tanasia Kenney, Kaitlyn Alanis, Mark Price, Vandana Ravikumar, and Don Sweeney also contributed to this report.

This story was originally published February 11, 2022 at 4:14 AM with the headline "Coronavirus weekly need-to-know: Cruises, travel warnings, declining COVID cases & more."

Julia Marnin
McClatchy DC
Julia Marnin covers courts for McClatchy News, writing about criminal and civil affairs, including cases involving policing, corrections, civil liberties, fraud, and abuses of power. As a reporter on McClatchy’s National Real-Time Team, she’s also covered the COVID-19 pandemic and a variety of other topics since joining in 2021, following a fellowship with Newsweek. Born in Biloxi, Mississippi, she was raised in South Jersey and is now based in New York State.
Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER